智慧型胰島素筆市場規模、佔有率、成長分析（按類型、按可用性、按產品、按連接類型、按適應症、按最終用戶、按地區）- 產業預測 2025-2032

2023 年智慧胰島素筆市場規模價值 45 億美元，預計將從 2024 年的 49.6 億美元成長到 2032 年的 108.7 億美元，預測期內（2025-2032 年）的複合年成長率為 10.3%。

由於對有效糖尿病管理解決方案的需求不斷增加，智慧胰島素筆市場正在經歷強勁成長。這些創新設備透過提供及時的提醒和警報來增強糖尿病患者的胰島素管理，確保劑量一致。與現有胰島素筆的兼容性增加了它的吸引力和易用性。透過輕鬆監測漏服劑量並維護全面的糖尿病狀況，這些筆對於管理第 1 型和第 2 型糖尿病都非常有價值。此外，還監測溫度範圍和有效期，以確保胰島素的安全處理。然而，COVID-19 疫情帶來了挑戰，限制了獲得基本糖尿病服務的機會，並導致糖尿病狀況無法控制。總體而言，智慧胰島素筆為糖尿病照護提供了一種方便有效的方法。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

智慧型胰島素筆市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 第一代筆
• 第二代筆

智慧胰島素筆市場規模（按可用性和複合年成長率） (2025-2032)

• 市場概覽
• 預先填充
• 可重複使用的

智慧胰島素筆市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 智慧胰島素筆
• 傳統筆適配器

智慧胰島素筆市場規模（按連接類型和複合年成長率）（2025-2032）

• 市場概覽
• Bluetooth
• USB

智慧胰島素筆市場規模（按適應症和複合年成長率） (2025-2032)

• 市場概覽
• 1型糖尿病
• 2型糖尿病

智慧胰島素筆市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診所
• 門診手術中心
• 家庭護理設置

智慧胰島素筆市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（USA）
• Medtronic plc（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Ypsomed Holding AG（Switzerland）
• Companion Medical（USA）
• Digital Medics Pty Ltd（Australia）
• Biocorp（France）
• Emperra GmbH（USA）
• E-Health Technologies（Germany）
• Bigfoot Biomedical, Inc.（USA）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（USA）
• Insulet Corporation（USA）
• Abbott Laboratories（USA）
• Terumo Corporation（Japan）
• Owen Mumford Ltd.（UK）
• SOOIL Development Co., Ltd.（South Korea）
• Pendiq GmbH（Germany）
• DarioHealth Corp.（Israel）

結論和建議

Smart Insulin Pens Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.96 billion in 2024 to USD 10.87 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The smart insulin pen market is experiencing robust growth driven by the increasing demand for effective diabetes management solutions. These innovative devices enhance insulin administration for diabetic patients by providing timely reminders and alerts, ensuring consistent dosing. Their compatibility with existing insulin pens adds to their appeal and ease of use. By facilitating the monitoring of missed doses and maintaining a comprehensive diabetes profile, these pens are invaluable for managing both type 1 and type 2 diabetes. Additionally, they ensure the safe handling of insulin by monitoring temperature ranges and expiration dates. However, the COVID-19 pandemic posed challenges, restricting access to necessary diabetic services and resulting in unmanaged diabetes profiles. Overall, smart insulin pens offer a convenient and efficient approach to diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Insulin Pens Market Segments Analysis

Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Insulin Pens Market

The surge in the diabetic population, driven by modern lifestyles and increased demands on the younger generation, has significantly accelerated the market for insulin products. Among these, smart insulin pens have gained considerable traction in recent years. As individuals grapple with the challenges of managing diabetes amidst hectic schedules, traditional methods of tracking glucose levels and insulin dosing become increasingly cumbersome. Smart technology offers a practical solution to these challenges, enhancing convenience and accuracy. Furthermore, the rising prevalence of needle stick injuries has further amplified the appeal of smart insulin pens, prompting manufacturers to ramp up production to capture growing demand and boost revenues in the upcoming years.

Restraints in the Smart Insulin Pens Market

The elevated price point of smart insulin pens could negatively impact their demand worldwide. In developing regions, particularly in Africa, inadequate healthcare systems and unfavorable reimbursement policies deter patients from pursuing necessary treatments and utilizing advanced devices like smart insulin pens. This financial barrier not only limits access to these innovative tools but also exacerbates existing health disparities, as individuals in these areas struggle to receive proper diabetes management solutions. Consequently, the high costs associated with these devices pose a significant challenge to their widespread adoption, particularly in underserved markets where the need for effective diabetes management is critical.

Market Trends of the Smart Insulin Pens Market

The smart insulin pens market is experiencing significant growth driven by advancements in healthcare technology and a rising global diabetic population. Innovative research and development initiatives are facilitating the creation of more sophisticated devices, enhancing patient engagement and management of diabetes. As market manufacturers introduce cutting-edge products that address the unique needs of insulin users, the landscape is evolving to offer greater convenience and accuracy in diabetes care. Moreover, the increasing adoption of digital health solutions and smart connectivity features in insulin pens are anticipated to present lucrative growth opportunities in the coming years, solidifying the market's trajectory.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Smart Insulin Pens Market Size by Type & CAGR (2025-2032)

• Market Overview
• First Generation Pens
• Second Generation Pens

Global Smart Insulin Pens Market Size by Usability & CAGR (2025-2032)

• Market Overview
• Prefilled
• Reusable

Global Smart Insulin Pens Market Size by Product & CAGR (2025-2032)

• Market Overview
• Smart Insulin Pen
• Adaptors for Conventional Pen

Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2025-2032)

• Market Overview
• Bluetooth
• USB

Global Smart Insulin Pens Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Smart Insulin Pens Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Global Smart Insulin Pens Market Size & CAGR (2025-2032)

• North America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocorp (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DarioHealth Corp. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations